Nav: Home

Exploring advancements in viral immunotherapies and vaccines in the melanoma field

December 12, 2016

The Future Science Group (FSG) published journal, Melanoma Management, has released a special issue highlighting the advancements made in viral immunotherapies and vaccines in the melanoma field.

Over the last few years, melanoma has been at the center of some of the latest advances in cancer immunotherapy, with monoclonal antibodies such as anti-CTLA-4 and anti-PD-1 currently FDA- approved for use in late stage disease. Moreover, focus is now being given to potential melanoma vaccines, comprised of tumor-associated antigens and intralesional viral therapies.

Highlights from the special issue include articles discussing how dendritic cell vaccines have developed since their inception to their use today in various clinical trials, as well as a comment on ongoing clinical trials for a variety of cancer vaccines. The issue further appraises various vaccine targets and intralesional therapies currently being developed for melanoma, as well as those already used in the clinic today, such as the oncolytic immunotherapy talimogene laherparepvec (T-VEC).

Guest Editor for the special issue, Robert O Dillman (AiVita Biomedical, CA, USA) stated: "This special focus issue of Melanoma Management highlights the latest advancements in melanoma immunotherapy with respect to cancer vaccines and viral-based therapies, with a range of articles discussing the developments in various vaccine candidates for melanoma as well as expert opinions and experiences with such vaccines both in clinical trials and in standard practice."

"The use of immunotherapies in melanoma has provided the field with exciting results and opened further avenues for treating the malignancy," commented commissioning editor for Melanoma Management Sebastian Dennis-Beron. "It has been a pleasure to work with a group of renowned experts on the fore-front of this field to develop this special issue on these immunotherapies, which could revolutionize melanoma treatment in the future".

View the special focus issue:

Dillman's foreword as guest editor is free to read, here:
About Melanoma Management

Melanoma Management launched in 2014 and is currently a quarterly forum for reviews, opinion, analysis and original research from international experts. The aim of our journal is to provide concise, up-to-date and clinically relevant content for the melanoma community through publication in both print and online formats and through our new partnership with Oncology Central (

About Future Science Group

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine. The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.

Future Science Group

Related Melanoma Articles:

Immunity against melanoma is only skin deep
Researchers at Dartmouth's Norris Cotton Cancer Center find that unique immune cells, called resident memory T cells, do an outstanding job of preventing melanoma in patients who develop the autoimmune disease, vitiligo.
Researchers document how melanoma tumors form
University of Iowa researchers have documented in continuous, real time how melanoma cells form tumors.
New driver, target in advanced mucosal melanoma
A University of Colorado Cancer Center study published March 15, 2017, in the journal Melanoma Research uses the unique resource of over 600 melanoma samples collected at the university to demonstrate, for the first time, novel mutations involved in mucosal melanoma, paving the way for therapies to treat this overlooked subtype.
NIH study reveals how melanoma spreads
Newly identified genes and genetic pathways in primary melanoma -- a type of skin cancer -- could give researchers new targets for developing new personalized treatments for melanoma, and potentially other cancers.
Melanoma research breakthrough gives hope to treatment
A QUT-driven project has identified the way in which melanoma cells spread, opening up new pathways to treatment via drugs to 'turn off' the invasive gene.
Study examines melanoma incidence, death
A new research letter published online by JAMA Dermatology updates information on trends in melanoma incidence and death in the United States since 2009.
Research providing promising new treatments for melanoma
In a paper published online Nov. 30, 2016, in Melanoma Management, Adam Riker, M.D., Professor of Surgery and Chief of Surgical Oncology at LSU Health New Orleans School of Medicine, reviews approaches to manage melanoma, including one tested at LSU Health New Orleans that provoked a complete response in a patient with a long history of the disease.
A protein that defines the melanoma blueprint
The latest study of the Melanoma Group at the Spanish National Cancer Research Centre describes the roles of CPEB4; a protein that is crucial for melanoma cell survival.
Nanotechnology supports treatment of malignant melanoma
Changes in the genetic make-up of tissue samples can be detected quickly and easily using a new method based on nanotechnology.
Detecting melanoma early, without a biopsy
Colorado State University Professor Jesse Wilson has received a one-year, $30,000 grant from the Colorado Clinical and Translational Sciences Institute to develop a new microscope that can distinguish between benign and malignant pigmented skin lesions, without the need for biopsy.

Related Melanoma Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...